Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Mucodyne 250 mg/5 ml Syrup.
Mucodyne 250 mg/5 ml Paediatric Syrup.
| Pharmaceutical Form |
|---|
|
Syrup. A clear amber-coloured syrupy liquid. |
Each 5 ml of oral solution contains 250 mg of Carbocisteine.
Excipient(s) with known effect:
Also contains 2 g of sucrose, 67.2 mg of ethanol (1.6% v/v), 7.5 mg of methyl parahydroxybenzoate (E218) and 32.52 mg of sodium (1.4 mmol).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carbocisteine |
Carbocisteine (5-carboxymethyl L-cysteine) has been shown in normal and bronchitic animal models to affect the nature and amount of mucus glycoprotein that is secreted by the respiratory tract. An increase in the acid:neutral glycoprotein ratio of the mucus and a transformation of serous cells to mucus cells is known to be the initial response to irritation and will normally be followed by hypersecretion. |
| List of Excipients |
|---|
|
Methyl parahydroxybenzoate (E218) |
*125 ml, 200 ml, 250 ml or 300 ml clear glass bottle (Type III glass) and a polypropylene childproof, tamper-evident screw cap with polyethylene liner together with a graduated polypropylene beaker for oral dose delivery to adults.
125 ml clear glass bottle (Type III glass) and a polypropylene childproof, tamper-evident cap with a polyethylene liner together with a 5 ml CE marked graduated syringe for oral dose delivery in children.
* The 125 ml pack size only will be provided with a syringe composed of a polyethylene barrel and a polystyrene piston with graduation markings each of 0.25 ml on the outside of the barrel.
Not all pack sizes may be marketed.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trading as:
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0204
Date of first authorisation: 03 November 1972
Date of latest renewal: 12 February 2003
| Drug | Countries | |
|---|---|---|
| MUCODYNE | Japan, Netherlands, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
